Rockwell Medical, Inc. (NASDAQ:RMTI) Short Interest Update

Rockwell Medical, Inc. (NASDAQ:RMTI) was the target of a large growth in short interest in September. As of September 15th, there was short interest totaling 1,550,000 shares, a growth of 52.0% from the August 31st total of 1,020,000 shares. Based on an average daily volume of 1,360,000 shares, the days-to-cover ratio is currently 1.1 days. Currently, 5.4% of the shares of the stock are short sold. Currently, 5.4% of the shares of the stock are short sold. Based on an average daily volume of 1,360,000 shares, the days-to-cover ratio is currently 1.1 days.

Rockwell Medical Price Performance

NASDAQ RMTI opened at $1.19 on Wednesday. The company has a quick ratio of 2.51, a current ratio of 2.89 and a debt-to-equity ratio of 0.30. The stock has a market capitalization of $40.97 million, a PE ratio of -19.83 and a beta of 1.73. Rockwell Medical has a 12-month low of $0.78 and a 12-month high of $5.15. The company has a 50 day moving average price of $1.30 and a two-hundred day moving average price of $1.13.

Rockwell Medical (NASDAQ:RMTI) last posted its earnings results on Thursday, August 14th. The company reported ($0.05) EPS for the quarter, hitting the consensus estimate of ($0.05). The company had revenue of $16.07 million during the quarter, compared to the consensus estimate of $16.33 million. Rockwell Medical had a negative net margin of 2.38% and a negative return on equity of 6.79%. Rockwell Medical has set its FY 2025 guidance at EPS. As a group, equities analysts predict that Rockwell Medical will post 0.03 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on RMTI. Weiss Ratings reiterated a “sell (d-)” rating on shares of Rockwell Medical in a report on Saturday, September 27th. Wall Street Zen upgraded shares of Rockwell Medical from a “sell” rating to a “hold” rating in a report on Saturday, June 14th. One research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $4.00.

Institutional Trading of Rockwell Medical

A hedge fund recently bought a new stake in Rockwell Medical stock. Panagora Asset Management Inc. acquired a new position in Rockwell Medical, Inc. (NASDAQ:RMTI) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 48,398 shares of the company’s stock, valued at approximately $41,000. Panagora Asset Management Inc. owned about 0.14% of Rockwell Medical at the end of the most recent quarter. Hedge funds and other institutional investors own 23.31% of the company’s stock.

About Rockwell Medical

Rockwell Medical, Inc, together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis.